How a 75-person San Diego biotech company went from zero formal security to SOC 2 Type I in 10 weeks.
Industry
Biotech / Pharma
Employees
75
Location
Torrey Pines, SD
Timeline
10 weeks
A San Diego biotech company developing novel therapeutics was in advanced negotiations for a $12M partnership with a Fortune 500 pharmaceutical company. The deal included sharing preclinical data and integrating research platforms -- but the enterprise partner required SOC 2 Type I certification as a prerequisite for data sharing.
The problem: the company had no formal security program. Their IT was managed by a two-person team focused on keeping systems running, not security. There was no documented security policy, no access reviews, no centralized logging, and no incident response plan. The deal had a 90-day deadline.
We mobilized a dedicated team within 48 hours of engagement. The approach was designed for speed without sacrificing substance -- every control implemented would hold up under audit scrutiny and provide real security value, not just checkbox compliance.
Achieved in 10 weeks with zero exceptions
In critical vulnerabilities within 30 days
Enterprise partnership secured on schedule
MDR coverage established from week 2
The SOC 2 certification became a competitive advantage. Within six months, the company closed two additional enterprise partnerships that required security attestation. They transitioned to SOC 2 Type II with a 12-month observation window, further strengthening their market position in San Diego’s competitive biotech landscape.
The security program we built did not just satisfy auditors -- it prevented two phishing attempts and one credential-stuffing attack during the first year of monitoring, protecting research data worth significantly more than the investment in security.